ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017
Correction: Synergistic Activity of PARP Inhibition by Talazoparib (BMN 673) with Temozolomide in Pediatric Cancer Models in the Pediatric Preclinical Testing Program.
No numbers read from the abstract.